Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
232.42
+2.23 (0.97%)
At close: Jun 12, 2025, 4:00 PM
232.42
0.00 (0.00%)
After-hours: Jun 12, 2025, 4:16 PM EDT
Bio-Rad Laboratories Employees
Bio-Rad Laboratories had 7,700 employees as of December 31, 2024. The number of employees decreased by 330 or -4.11% compared to the previous year.
Employees
7,700
Change (1Y)
-330
Growth (1Y)
-4.11%
Revenue / Employee
$330,013
Profits / Employee
-$281,052
Market Cap
6.32B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7,700 | -330 | -4.11% |
Dec 31, 2023 | 8,030 | -170 | -2.07% |
Dec 31, 2022 | 8,200 | 300 | 3.80% |
Dec 31, 2021 | 7,900 | -100 | -1.25% |
Dec 31, 2020 | 8,000 | -120 | -1.48% |
Dec 31, 2019 | 8,120 | -140 | -1.69% |
Dec 31, 2018 | 8,260 | 110 | 1.35% |
Dec 31, 2017 | 8,150 | -100 | -1.21% |
Dec 31, 2016 | 8,250 | 480 | 6.18% |
Dec 31, 2015 | 7,770 | 170 | 2.24% |
Dec 31, 2014 | 7,600 | -150 | -1.94% |
Dec 31, 2013 | 7,750 | 370 | 5.01% |
Dec 31, 2012 | 7,380 | 350 | 4.98% |
Dec 31, 2011 | 7,030 | 150 | 2.18% |
Dec 31, 2010 | 6,880 | 280 | 4.24% |
Dec 31, 2009 | 6,600 | 0 | - |
Dec 31, 2008 | 6,600 | 200 | 3.13% |
Dec 31, 2007 | 6,400 | 1,000 | 18.52% |
Dec 31, 2006 | 5,400 | 200 | 3.85% |
Dec 31, 2005 | 5,200 | 0 | - |
Dec 31, 2004 | 5,200 | 400 | 8.33% |
Dec 31, 2003 | 4,800 | 200 | 4.35% |
Dec 31, 2002 | 4,600 | 300 | 6.98% |
Dec 31, 2001 | 4,300 | 500 | 13.16% |
Dec 31, 2000 | 3,800 | -300 | -7.32% |
Dec 31, 1999 | 4,100 | 1,425 | 53.27% |
Dec 31, 1998 | 2,675 | 25 | 0.94% |
Dec 31, 1997 | 2,650 | 115 | 4.54% |
Dec 31, 1996 | 2,535 | 75 | 3.05% |
Dec 31, 1995 | 2,460 | 130 | 5.58% |
Dec 31, 1994 | 2,330 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
BIO News
- 14 days ago - Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference - Business Wire
- 4 weeks ago - Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference - Business Wire
- 5 weeks ago - Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Bio-Rad Reports First-Quarter 2025 Financial Results - Business Wire
- 4 months ago - Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results - Business Wire
- 4 months ago - Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies - Business Wire
- 4 months ago - Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025 - Business Wire